To date, investigations into the function of USP22 in breast cancer have been solely limited to in vitro studies and immunohistochemical staining of tumor samples and did not specifically investigate its relevance in HER2+-BC [10, 18, 48]. This evidence concerns the gene ERBB2 and breast cancer.